SciClone Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 81   

Articles published

SCLN 11.06 -0.18 (-1.60%)
price chart
Sciclone Pharmaceuticals Inc (SCLN) Files Form 4 Insider Selling : Friedhelm ...
Sciclone Pharmaceuticals Inc (SCLN): Friedhelm Blobel , President & CEO of Sciclone Pharmaceuticals Inc sold 10,000 shares on Jun 26, 2015.
MLV & Co. Initiates SciClone Pharmaceuticals At Buy  Benzinga
Friedhelm Blobel the President & CEO of SciClone Pharmaceuticals, Inc ...  OctaFinance.com
Why SciClone Pharmaceuticals, Inc. Is Surging Higher
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry With The ...  Benzinga
Analyst Price Target Update on SciClone Pharmaceuticals, Inc.
SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN): 2 Analyst have given the stock of SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) a near short term price target of $11.5. The standard deviation reading, which is a measure by which the stock price is ...
SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) Analyst Rating Update  News Watch International
Should You Buy Surging SciClone Pharmaceuticals (SCLN), Up By 14.66 ...  Insider Monkey (blog)
Is SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) Stock a Sell after Friedhelm ...
Company insider, Friedhelm Blobel, President & CEO of SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) 9.16 -0.20 -2.14% sold a total of 10,000 shares of the firm, based on a stock price of $9.1 per every share.
Insider Selling: Friedhelm Blobel Sells 10000 Shares of SciClone ...  Dakota Financial News
SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)'s President & CEO Friedhelm ...
Recently, an insider trading deal was made. Friedhelm Blobel, the President & CEO and an insider of SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) 9.30 -0.08 -0.85% sold exactly 10,000 shares of Sciclone Pharmaceuticals Inc, worth approximately ...
SciClone Pharmaceuticals Inc. (SCLN) is Trading Lower on Unusual Volume for ...
SciClone Pharmaceuticals Inc. (SCLN) experienced unusually high volume on Jul. 02, as the stock lost 1.6% to a closing price of $11.06.
SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)'s director Richard Hawkins ...
Mr. Richard Hawkins, the crucial director at SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) 9.38 +0.01 0.11% has recently been linked with sold via broker of 4,570 shares of the company, valued at $9.3 per share.
SciClone Pharmaceuticals Director Richard J. Hawkins Sells 4570 Shares (SCLN)  The Legacy
Insider Selling: Richard J. Hawkins Sells 4570 Shares of SciClone ...  WKRB News
Richard Hawkins an Insider in SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN ...
The insider, and SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) 9.38 +0.01 0.11% 's director, Richard Hawkins, unloaded 11,982 company shares on May 26, 2015, valued by the market at around $113,145 (at $9.4 for each share).
Insider Selling at Sciclone Pharmaceuticals Inc (SCLN) : Richard J Hawkins ...  Money Flow Index
Insider Selling: SciClone Pharmaceuticals Director Sells $113110.08 in Stock ...  Dakota Financial News
Sciclone Pharmaceuticals Inc (SCLN) Discloses Form 4 Insider Selling ...
Sciclone Pharmaceuticals Inc (SCLN) Discloses Insider Transaction. Friedhelm Blobel , President & CEO of Sciclone Pharmaceuticals Inc sold 10,000 shares on Jun 12, 2015. The Insider selling transaction was disclosed on Jun 15, 2015 to the Securities ...
Sciclone Pharmaceuticals Inc (SCLN) Discloses Form 4 Insider Selling : Chuncai ...
Sciclone Pharmaceuticals Inc (SCLN) Discloses Insider Transaction. Chuncai Meng , Gen. Counsel & VP Compliance of Sciclone Pharmaceuticals Inc sold 3,007 shares on Jun 12, 2015. The Insider selling transaction was disclosed on Jun 15, 2015 to the ...
Friedhelm Blobel an Insider in SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN ...  OctaFinance.com